INTERIM BIOMARKER ANALYSES OF PHASE II STUDY DATA ON SAFETY AND EFFICACY OF GM-CSF/LEUKINE® IN MILD-TO-MODERATE AD
- Resource Type
- Abstract
- Source
- In
Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P1517-P1518 - Subject
- Language
- ISSN
- 1552-5260